Researchers in Germany have developed a new way to build tiny, high tension molecular structures called “housanes” using nothing more than light and a special catalyst, opening a faster and cleaner path to creating complex compounds used in medicines including antibiotics like penicillin. The breakthrough solves a long standing challenge in chemistry where these valuable building blocks were previously too difficult or costly to produce.
The method, led by Professor Frank Glorius at the University of Münster’s Institute of Organic Chemistry, transforms simple starting materials called 1,4-dienes into housanes, so named because their shape resembles a child’s drawing of a house. The key is a photocatalyst that absorbs light energy and transfers it to the molecules, providing the push needed for the reaction to occur. Small ring molecules like housanes store enormous internal tension, similar to a bent branch under pressure. When they later release that energy, they become powerful tools for building useful chemicals and pharmaceuticals efficiently.
Earlier attempts to make housanes required high temperatures and harsh conditions, and they often failed when scientists tried to attach functional groups: the extra atoms or side chains that determine how a drug molecule behaves in the body. The Münster team solved this by adjusting the molecular side chains of the starting materials to block unwanted side reactions. Once those competing pathways were suppressed, the molecules folded into the strained ring structure needed. Professor Glorius explained that the process is “energetically uphill” and requires additional momentum, which the photocatalyst provides. The team also used computer analyses to map the reaction mechanism in detail.
The new technique offers a more efficient and accessible way to produce housanes while expanding the range of molecules that can be built from these high tension structures. Researchers believe the method could support both fundamental chemistry and practical applications, including pharmaceutical manufacturing and the development of advanced materials. The next steps involve refining the process for industrial scale use and exploring which specific drug targets might benefit first from housane based synthesis.